[Translation] Phase I of a single-center, blinded, placebo and positive vaccine parallel control design to initially explore the safety, tolerability and immunogenicity of the quadrivalent influenza virus split vaccine (MDCK cell) in healthy people aged 6 months and above Clinical Trials
主要目的:
四价流感病毒裂解疫苗(MDCK细胞)在6月龄及以上健康人群中接种的安全性。
次要目的:
四价流感病毒裂解疫苗(MDCK细胞)在6月龄及以上健康人群中接种的免疫原性。
探索性目的:
探索3~8岁人群以2种免疫程序接种四价流感病毒裂解疫苗(MDCK细胞)的免疫原性。
[Translation] main purpose:
Safety of quadrivalent influenza virus split vaccine (MDCK cell) in healthy people aged 6 months and above.
Secondary purpose:
Immunogenicity of quadrivalent influenza virus split vaccine (MDCK cell) in healthy people aged 6 months and above.
Exploratory purpose:
To explore the immunogenicity of quadrivalent influenza virus split vaccine (MDCK cell) in people aged 3 to 8 years old using two immunization schedules.